Difficult-To-Treat Infections

BOSTON — More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, findings showed.

WASHINGTON — Vosevi, a triple-combination therapy for chronic hepatitis C virus infection, was effective when used as a rescue treatment in patients who did not achieve sustained virologic response with direct-acting antiviral agents.